BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 26381522)

  • 1. Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy.
    Koo T; Song C; Kim JS; Kim K; Chie EK; Kang SB; Lee KW; Kim JH; Jeong SY; Kim TY
    PLoS One; 2015; 10(9):e0138728. PubMed ID: 26381522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
    Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
    Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
    Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
    Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection.
    Lee SD; Kim TH; Kim DY; Baek JY; Kim SY; Chang HJ; Park SC; Park JW; Oh JH; Jung KH
    Eur J Surg Oncol; 2012 Jun; 38(6):478-83. PubMed ID: 22465588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ratio of metastatic lymph nodes is more important for rectal cancer patients treated with preoperative chemoradiotherapy.
    Park IJ; Yu CS; Lim SB; Yoon YS; Kim CW; Kim TW; Kim JH; Kim JC
    World J Gastroenterol; 2015 Mar; 21(11):3274-81. PubMed ID: 25805934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the Lymph Node Ratio to Evaluate the Prognosis of Stage II/III Breast Cancer Patients Who Received Neoadjuvant Chemotherapy and Mastectomy.
    Wu SG; Li Q; Zhou J; Sun JY; Li FY; Lin Q; Lin HX; Gaun XX; He ZY
    Cancer Res Treat; 2015 Oct; 47(4):757-64. PubMed ID: 25672578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node ratio and surgical quality are strong prognostic factors of rectal cancer: results from a single referral centre.
    Leonard D; Remue C; Abbes Orabi N; van Maanen A; Danse E; Dragean A; Debetancourt D; Humblet Y; Jouret-Mourin A; Maddalena F; Medina Benites A; Scalliet P; Sempoux C; Van den Eynde M; De Schoutheete JC; Kartheuser A
    Colorectal Dis; 2016 Jun; 18(6):O175-84. PubMed ID: 27128602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant therapy does not affect lymph node ratio in rectal cancer.
    Chang KH; Kelly NP; Duff GP; Condon ET; Waldron D; Coffey JC
    Surgeon; 2016 Oct; 14(5):270-3. PubMed ID: 26148760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].
    Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of lymph node retrieval and lymph node ratio following preoperative chemoradiation of rectal cancer.
    La Torre M; Mazzuca F; Ferri M; Mari FS; Botticelli A; Pilozzi E; Lorenzon L; Osti MF; Marchetti P; Enrici RM; Ziparo V
    Colorectal Dis; 2013 Jul; 15(7):e382-8. PubMed ID: 23581854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node identification following neoadjuvant therapy in rectal cancer: A stage-stratified analysis using the surveillance, epidemiology, and end results (SEER)-medicare database.
    Ecker BL; Paulson EC; Datta J; Jeganathan AN; Aarons C; Kelz RR; Mahmoud NN
    J Surg Oncol; 2015 Sep; 112(4):415-20. PubMed ID: 26250884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the pathological regression level of metastatic lymph nodes associated with oncologic outcomes following preoperative chemoradiotherapy in rectal cancer?
    Choi JP; Kim SJ; Park IJ; Hong SM; Lee JL; Yoon YS; Kim CW; Lim SB; Lee JB; Yu CS; Kim JC
    Oncotarget; 2017 Feb; 8(6):10375-10384. PubMed ID: 28060748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of axillary lymph node status after neoadjuvant chemotherapy. Results from a multicentre study.
    Saxena N; Hartman M; Aziz R; Rapiti E; Bhoo Pathy N; Lim SE; Iau P; Taib NA; Schaffar R; Neyroud-Caspar I; Yip CH; Lee SC; Verkooijen HM
    Eur J Cancer; 2011 May; 47(8):1186-92. PubMed ID: 21239165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer.
    Tsai J; Bertoni D; Hernandez-Boussard T; Telli ML; Wapnir IL
    Ann Surg Oncol; 2016 Oct; 23(10):3310-6. PubMed ID: 27401442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
    Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
    Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of lymph node ratios in node positive rectal cancer treated with preoperative chemoradiation.
    Nadoshan JJ; Omranipour R; Beiki O; Zendedel K; Alibakhshi A; Mahmoodzadeh H
    Asian Pac J Cancer Prev; 2013; 14(6):3769-72. PubMed ID: 23886180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of lymph node ratio staging system in stage III( rectal cancer following 30 Gy/10 f preoperative radiotherapy].
    Wang L; Li Z; Li M; Peng Y; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Oct; 17(10):990-6. PubMed ID: 25341906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.
    Renaud S; Falcoz PE; Olland A; Reeb J; Santelmo N; Massard G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
    Madbouly KM; Abbas KS; Hussein AM
    Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.